Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Richard Greil

TCL1 Transgenic Mice as a Model for CD49d-high Chronic Lymphocytic Leukemia

Leukemia

English

Influence of the American ODAC Statement on Austrian Bevacizumab Prescribing Practice for Metastatic Breast Cancer

English

Oncogenic Role of miR-155 in Anaplastic Large Cell Lymphoma Lacking the T(2;5) Translocation

English

Utility of PCR in Diagnosis of Invasive Fungal Infections: Real-Life Data From a Multicenter Study

Journal of Clinical Microbiology

Microbiology

2012

English

Impact of Tumour RAS/BRAF Status in a First-Line Study of Panitumumab + FOLFIRI in Patients With Metastatic Colorectal Cancer

British Journal of Cancer

Cancer Research

Oncology

2016

English

CXCL12-induced VLA-4 Activation Is Impaired in Trisomy 12 Chronic Lymphocytic Leukemia Cells: A Role for CCL21

Oncotarget

Oncology

2015

English

Therapy Line and Associated Predictors of Response to PD-1/PD-L1-Inhibitor Monotherapy in Advanced Non-Small-Cell Lung Cancer: A Retrospective Bi-Centric Cohort Study

English

Interdependent Regulation of P53 and miR-34a in Chronic Lymphocytic Leukemia

Cell Cycle

Medicine

Developmental Biology

Cell Biology

Molecular Biology

2010

English

Overcoming Resistance Against HER2-Targeting Agents in Fifth-Line Therapy: Is There Still a Place for Bevacizumab in HER2+ Breast Cancer?

Clinical Breast Cancer

Cancer Research

Oncology

2014

English

Sidedness and TP53 Mutations Impact OS in Anti-Egfr but Not Anti-Vegf Treated mCRC - An Analysis of the KRAS Registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie)

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Richard Greil

TCL1 Transgenic Mice as a Model for CD49d-high Chronic Lymphocytic Leukemia

Influence of the American ODAC Statement on Austrian Bevacizumab Prescribing Practice for Metastatic Breast Cancer

Oncogenic Role of miR-155 in Anaplastic Large Cell Lymphoma Lacking the T(2;5) Translocation

Utility of PCR in Diagnosis of Invasive Fungal Infections: Real-Life Data From a Multicenter Study

Impact of Tumour RAS/BRAF Status in a First-Line Study of Panitumumab + FOLFIRI in Patients With Metastatic Colorectal Cancer

CXCL12-induced VLA-4 Activation Is Impaired in Trisomy 12 Chronic Lymphocytic Leukemia Cells: A Role for CCL21

Therapy Line and Associated Predictors of Response to PD-1/PD-L1-Inhibitor Monotherapy in Advanced Non-Small-Cell Lung Cancer: A Retrospective Bi-Centric Cohort Study

Interdependent Regulation of P53 and miR-34a in Chronic Lymphocytic Leukemia

Overcoming Resistance Against HER2-Targeting Agents in Fifth-Line Therapy: Is There Still a Place for Bevacizumab in HER2+ Breast Cancer?

Sidedness and TP53 Mutations Impact OS in Anti-Egfr but Not Anti-Vegf Treated mCRC - An Analysis of the KRAS Registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie)